Over 130 million people in my country suffer from chronic kidney disease (CKD)， most of whom are chronically troubled by hypertension， proteinuria， and a continuous decline in kidney function. Traditional medications have many side effects， and interventional surgeries are invasive. Now， thanks to the Boao Lecheng pilot program， the Israeli Nephrospec low-intensity renal shockwave therapy device has been officially launched. Over ten years of overseas clinical trials have proven its non-invasiveness and safety. Recently， CKD patients from all over the country have been making special trips to Lecheng for appointments and evaluations. Today， we will fully analyze its core functions and suitable population.

　　It ≠ Kidney Stone Lithotripsy Machine

　　Lithotripsy machines use high energy and can easily damage the kidneys; this therapy uses only 10% of that energy， focusing on repair rather than stone fragmentation， with no radiation and no need for anesthesia.

　　Five Core Kidney-Protecting Effects (Clinically Verified)

　　1. Regenerating Renal Microvessels， Improving Ischemia and Hypoxia

　　Upregulating angiogenesis factors， increasing renal cortical microvessel density by 40%-60%， relieving nocturia， lower back pain， and fatigue.

　　2. Anti-inflammatory and anti-fibrotic， delaying dialysis

　　Reduces kidney sclerosis， decreasing fibrosis by 30%-50%， clinically delaying dialysis by more than 12 months.

　　3. Stable control of renal hypertension

　　Systolic blood pressure decreases by an average of 10-19 mmHg after treatment， reducing the side effects of using multiple antihypertensive drugs in combination.

　　4. Reduces proteinuria and protects glomeruli

　　Repairs the podocyte barrier; proteinuria in diabetic nephropathy patients can decrease by up to 87%， stabilizing creatinine.

　　5. Activates autologous stem cells to repair kidney tissue

　　Mobilizes stem cells to repair damaged renal tubules， stabilizing eGFR and protecting remaining renal function.

　　Standard Treatment Procedure

　　A complete treatment course lasts 3 weeks， twice a week， for a total of 6 sessions; each session involves prone ultrasound localization， bilateral kidney 4800 shockwaves， 30-60 minutes per session， patients can leave immediately after completion. The equipment is EU CE certified， has been used clinically overseas for over ten years， and is a compliant and licensed import from Lecheng.

　　Suitable Candidates

　　Patients with stage 3-4 CKD hypertensive nephropathy， diabetic nephropathy， or renal artery stenosis; those whose blood pressure/proteinuria is poorly controlled by multiple medications， whose renal function is continuously declining， and who wish to delay dialysis.

　　Excellent safety profile， with only mild self-limiting reactions.

　　Over ten years of global adverse event monitoring， with no severe complications such as renal hematoma or renal necrosis：

　　1. A small number of people may experience short-term lower back pain， which resolves spontaneously within 3-4 days;

　　2. In rare cases， transient microscopic hematuria or slight fluctuations in creatinine may occur， which resolves within 2 weeks with rehydration;

　　3. The entire procedure is radiation-free， does not damage normal kidney tissue， and may even reduce kidney damage caused by lithotripsy.

　　Want to schedule a non-invasive renal shockwave assessment at Lecheng？ Send a private message with "Kidney Preservation Appointment" to receive detailed information on the clinic address， assessment and examination list， and treatment details.